FDA APPROVES NIVOLUMAB WITH IPILIMUMAB FOR UNRESECTABLE OR METASTATIC HEPATOCELLULAR CARCINOMA

Reuters · 04/11 14:32

Please log in to view news

Recently
Symbol
Price
%Change